demo: foo bar baz
I am the FIRST
regular 4 post ff
Section1 headline
Section1 are body
infinite scroll 4 pff
Sanofi, GSK COVID vaccine shows strong immune response in phase 2 trials
Sanofi and GSK announcedthis morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial.
Why it matters: Sanofi and GSK say their recombinant protein-based vaccine candidate could ultimately serve as a universal COVID-19 vaccine booster, able to boost immunity regardless of the vaccination first received.
Biden's push for fiber revives a Google dream
President Biden's plan to boost broadband across the country could also be a boon to Google's internet ambitions.
Why it matters: Biden wants to invest billions in building "future-proof" networks to connect all Americans, using a technology that Google previously struggled to deploy widely.
New memos show how top FDA officials thought slim evidence was enough for Alzheimer drug approval
FDA statisticians did not believe experimental Alzheimer's treatment Aduhelm proved that it could slow down the cognitive disease, but the top brass at the agency thought there was enough evidence to approve the drug anyway, according to internal documents released by the FDA today.
Why it matters: Outside experts almost unanimously voted down the drug, and the scientific community has blasted the FDA's approval of Aduhelm. But FDA leaders repeatedly cited "the urgent and unmet medical need" for Alzheimer's treatments.
The world's population growth is slowing, and that's OK
Population growth is continuing to slow in the U.S. and China — the world’s top two economies — but that’s not necessarily a bad thing.
Why it matters: While population trends can be difficult to change, there is unlikely to be a “point of no return" where they can't be reversed — if government leaders proactively address the foundational causes, like the burdens and costs of child care or fears of immigration.